4Millington DS;Kodo N;Norwood DL.Tandem mass spectrometry:a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism[J],1990.
5Chace DH;Kalas TA;Naylor.The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism[J],2002(0).
6Zytkovicz TH;Fitzgerald EF;Marsden D.Tandem mass spectrometry analysis for amino,organic,and fatty acid disorders in newborn dried blood spots:a two-year summary from the New England newborn screening program,2001.
7WILEY V;Carpenter K, Wilcken.Newborn Screening with tandem mass spectrometry:12 months experience in NSW Australia,1999.
8Jones PM;Bennett MJ.The changing face of newborn screening:diagnosis of inborn errors of metabolism by tandem mass spectrometry[J],2002.
9Levy HL.Newborn screening by tandem mass spectrometry:a new era,1998.
10Shigematsu Y;Hirano S;Hata I.Newborn mass screening and selective screening using elctrospray tandem mass spectrometry in Japan[J],2002(1).
7DA Applegarth, JR Toone, RB Lowry. Incidence of inborn errors ofmetabolism in British Columbia,1969-1996[J]. Pediatrics, 2000,105: 10.
8C Dionisi -Vici, C Rizzo, AB Burlina, et al. Inborn errors ofmetabolism in the Italian pediatric population: a nationalretrospective survey[j]. J Pediatr, 2002, 140:321-327.
9S Sanderson, A Green, MA Preece, et al. The incidence of inheritedmetabolic disorders in the West Midlands, UK[j]. Arch Dis Child,2006 , 91: 321-327.
10Guthrie R, Susi A. A simple phenylalanine anine method fordetecting phenyletonuria in large populations of newborn infants [j].Pediatrics, 1963, 32: 338-343.
